Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biomea Fusion, Inc. - Common Stock
(NQ:
BMEA
)
1.170
-0.020 (-1.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomea Fusion, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
US Stocks Edge Lower; Bank of America Profit Tops Views
↗
January 13, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 50 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
January 13, 2023
Via
Benzinga
Biomea Fusion to Present at 41st Annual J.P. Morgan Healthcare Conference and Highlight 2023 Corporate Milestones
January 09, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces Dosing of First Patient with Type 2 Diabetes in the United States in Ongoing Phase I/II (COVALENT-111) Study of BMF-219
January 04, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion: Q2 Earnings Insights
↗
August 01, 2022
Biomea Fusion (NASDAQ:BMEA) reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent Menin Inhibitor BMF-219 in Type 2 Diabetes
December 14, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Presents at the 2022 ASH Annual Meeting Preclinical Data on BMF-500 Supporting its Potential as the Most Potent and Selective FLT3 Inhibitor to Date
December 12, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Is Ardelyx is A Buy After Slip in Early 2022
November 21, 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them
Via
MarketBeat
Biomea Fusion to Participate in Piper Sandler 34th Annual Healthcare Conference
November 11, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Reports Third Quarter 2022 Financial Results and Business Highlights
November 07, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion to Present Preclinical Data for BMF-500, an Investigational Oral Covalent FLT3 Inhibitor, at the 64th American Society of Hematology (ASH) Annual Meeting
November 03, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
↗
November 01, 2022
Upgrades
Via
Benzinga
Biomea Fusion Announces Dosing of First Patient with Type 2 Diabetes and Completion of Phase I Healthy Volunteer Portion of Phase I/II (COVALENT-111) Study of BMF-219
October 31, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces First Patient Dosed with Chronic Lymphocytic Leukemia (CLL) in COVALENT-101 Trial
October 27, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
BMF-219 Enters the Clinic for KRAS Solid Tumors
October 14, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
↗
August 26, 2022
Via
Benzinga
Biomea Fusion Touts Additional Preclinical Data For Blood Cancer Candidate
↗
August 26, 2022
Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of two posters at the 19th International Myeloma Society (IMS) Annual Meeting.
Via
Benzinga
How Is The Market Feeling About Biomea Fusion?
↗
August 18, 2022
Biomea Fusion's (NASDAQ:BMEA) short percent of float has fallen 17.37% since its last report. The company recently reported that it has 451 thousand shares sold short,...
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
↗
August 18, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 17, 2022
Via
Benzinga
Biomea Fusion Commences Initial-Stage Study For Plasma Cell Cancer Setting
↗
June 22, 2022
Biomea Fusion (NASDAQ: BMEA) has dosed the the first patient in the multiple myeloma (MM) cohort of the Phase I clinical trial evaluating BMF-219, a covalent menin inhibitor. Multiple myeloma (MM) is a...
Via
Benzinga
69 Biggest Movers From Yesterday
↗
June 10, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.
Via
Benzinga
79 Biggest Movers From Yesterday
↗
June 08, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 01, 2022
Gainers
Via
Benzinga
62 Biggest Movers From Yesterday
↗
June 02, 2022
Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.
Via
Benzinga
48 Stocks Moving In Tuesday's Mid-Day Session
↗
May 17, 2022
Gainers Okyo Pharma Ltd. ADR (NASDAQ: OKYO) gained 30% to $5.20 as the company priced its IPO at $4 per ADS.
Via
Benzinga
81 Biggest Movers From Yesterday
↗
May 18, 2022
Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 03, 2022
Via
Benzinga
80 Biggest Movers From Yesterday
↗
May 04, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
